AAPG: ascentage.com Narx-foyda va o‘sish multiplikatori
Ascentage Pharma Group (AAPG) muvaffaqiyati onkologik dori vositalarining tijoratlashtirilishi va tartibga soluvchi organlar tomonidan tasdiqlanishiga asoslangan. PEG koeffitsiyentining o'zgarishi ushbu bog'liqlikni vizuallashtiradi, bunda 0.00 belgisi fundamental qiymatning joriy ko'rsatkichi bo'lib xizmat qiladi. Kelajakda daromadlar maqsadli terapiya vositalarining sotuvlariga tayanadi, tadqiqotlar barqarorligi esa biosimplar uchun qat'iy kalibrlangan transchegaraviy logistika orqali ta'minlanadi.
Ascentage Pharma Group (AAPG) kompaniyasining tahliliy kesimlari
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning kapitalga nisbati Ascentage Pharma Group|AAPG - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati ascentage.com|AAPG - Kompaniya qarzlari|Sof aktivlarga qarzlar Ascentage|AAPG - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Ascentage Pharma|Shoshilinch likvidlik ascentage.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
AAPG - Kompaniyaning sof foydasi|Sof foyda prognozi Ascentage Pharma Group|AAPG - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati Ascentage Pharma Corp|AAPG - PEG multiplikatori|EV/EBITDA multiplikatori Ascentage|AAPG - EBITDA operatsion foydasi|Sirpanuvchi yil uchun bir aksiya uchun sof foyda Ascentage Pharma|AAPG - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi ascentage.com|AAPG - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Ascentage Pharma Group
Kompaniyaning fundamental tahlili:AAPG, Ascentage Pharma Group International
Ascentage Pharma Group (AAPG) tomonidan yangi onkologik dori vositalarini ishlab chiqish yuqori kapital xarajatlarini va klinik natijalarga oid noaniqliklarni rag'batlantiradi. PEG koeffitsiyenti aksiyaning bozor qiymatini foyda o'sish sur'atlari bilan solishtiradi va qiymat birdan past bo'lganda biznesning qadrsizlanganini aniqlaydi, bu esa biofarmatsevtika sektoridagi shiddatli raqobat sharoitida kompaniyaning o'sish potentsialini baholash uchun juda muhimdir.
Raqobatdosh kompaniyalar
ONC (BeiGene Ltd.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori HALO (Halozyme Inc.)|RVMD - Narx-foyda va o‘sish multiplikatori|CGON: Narx-foyda va o‘sish multiplikatori|URGN - PEG multiplikatori|Bicara Therapeutics (BCAX) - Narxning foydaga va o‘sish sur’atiga nisbati|Personalis Inc - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|ERAS (Erasca Corp) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Delcath Corp DCTH|PEG multiplikatori YMAB|PEG multiplikatori aurabiosciences.com (AURA)|Narxning foydaga va o‘sish sur’atiga nisbati Candel Therapeutics, Inc. CADL|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Accuray Inc (ARAY)|SELLAS Life Sciences Group Inc. - PEG multiplikatori|Actuate Therapeutics Inc (ACTU) - Narx-foyda va o‘sish multiplikatori|CTOR: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda TuHURA Biosciences (HURA)|Narxning foydaga va o‘sish sur’atiga nisbati Protara Therapeutics, Inc.|O‘sishni hisobga olgan narx-foyda koeffitsiyenti FATE (Fate Therapeutics Inc)|Narx-foyda va o‘sish multiplikatori WHWK (Aadi Bioscience Inc)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati TCRX|PEG multiplikatori CSBR (Champions Oncology, Inc.)|PEG multiplikatori XBiotech Inc XBIT|CEL-SCI Corp - PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati OS Therapies Inc. (OSTX)|RADX: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Artiva Biotherapeutics (ARTV)|Narx-foyda va o‘sish multiplikatori ANL|VERU: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Tempest Therapeutics, Inc. (TPST)|XLO: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori RENB (Renovaro)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti MURA|Kairos Pharma Inc - PEG multiplikatori|OKUR - PEG multiplikatori|w2.cytomed.sg (GDTC) - Narxning foydaga va o‘sish sur’atiga nisbati|Curis - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Apollomics Inc.|Narx-foyda va o‘sish multiplikatori Tharimmune Corporation (THAR)|PEG multiplikatori ADVB|PEG multiplikatori genprex.com (GNPX)|Calidi Biotherapeutics, Inc. - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti SBFM|Xenetic Bio - PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati Salarius Pharma (SLRX)|Purple Biotech (PPBT) - Narxning foydaga va o‘sish sur’atiga nisbati|American Oncology Network, Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati BeiGene|O‘sish sur’atiga tuzatilgan narx-foyda Checkpoint Therapeutics Inc. CKPT|Narx-foyda va o‘sish multiplikatori ELEV (Elevation Oncology, Inc.)|PEG multiplikatori icadmed.com (ICAD)|Narxning foydaga va o‘sish sur’atiga nisbati Ikena Oncology IKNA|NTBL (notablelabs.com) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Viracta - PEG multiplikatori|MOR - PEG multiplikatori|NAYA: PEG multiplikatori|Ascentage (AAPGV) - PEG multiplikatori
